Search

The fate of per- and polyfluoroalkyl substances (PFASs) derived from aqueous film forming foam (AFFF) was investigated within a wastewater treatment plant (WWTP) receiving large AFFF inputs from a foam refractory testing event. Targeted analysis, the Total Oxidizable Precursor Assay (TOP Assay), and nontargeted analysis with quadrupole time-of-flight (QTOF) were used to characterize the samples. Over the duration of foam testing, approximately 10.8 kg of total PFASs was measured by TOP Assay in the influent, and 6.3 kg of total PFASs was measured in the effluent; 94 g of PFOS was released in the effluent, apparently from remobilization of historical sources. 1.7% of total PFASs measured in the influent were converted to short chain perfluoroalkyl carboxylates in the effluent. Ten PFAS classes previously reported, including 6:2 fluorotelomer thioether amido sulfonate (6:2 FtTAoS), and 5 PFAS classes newly reported were identified by QTOF. The trickling filter was the only unit operation that resulted in significant gains and losses of individual PFASs, including near complete loss of 6:2 FtTAoS due to transformation. Similar reaction pathways for 6:2 FtTAoS reported in previously published soil and activated sludge microcosm experiments were observed in this WWTP, although a higher yield of perfluoroheptanoic acid was observed.

After several decades of widespread use, some per- and polyfluoroalkyl substances (PFASs) were phased-out of use due to concerns raised by their persistent, bioaccumulative, and toxic properties. Our objective was to evaluate temporal trends in serum PFAS levels among 1257 middle-aged and older California women (ages 40-94) during a four year period, beginning approximately 5-10 years after these phase-outs began. An online SPE-HPLC-MS/MS was used to measure 10 long-chain PFASs in serum from blood collected cross-sectionally during 2011-2015 from a subset of participants in the California Teachers Study. Results from multivariable linear regression analyses indicated that serum concentrations of nearly all PFASs declined on average 10% to 20% per year. Serum levels of perfluorohexanesulfonic acid (PFHxS) did not significantly decline. With the exception of PFHxS, the downward trend in serum concentrations was evident for all PFASs across all ages, although declines were comparatively steeper among the oldest women. These findings suggest that the phase-out of some common PFASs has resulted in reduced human exposures to them. The lack of a decline for PFHxS suggests that these exposures may be ongoing and underscores the importance of continued biomonitoring and research efforts to elucidate current pathways of exposure.